Over the past year, inflation and rising interest rates drove investors toward safer, defensive stocks. That's why blue-chip stalwarts like Procter & Gamble (NYSE: PG), Colgate-Palmolive (NYSE: CL), and Coca-Cola (NYSE: KO) all outperformed the S&P 500 over the past 12 months.
Procter & Gamble (PG) closed the most recent trading day at $126.25, moving -1.9% from the previous trading session.
If you're not familiar with Vertex Pharmaceuticals (NASDAQ: VRTX), this healthcare stock is certainly one to put on your radar. The company develops and manufactures medicines that treat rare diseases. As of right now, it has four approved products, and all of them treat cystic fibrosis.